N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine

C173H165N45O5S9 — CID 157330416

IUPACN,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine
SMILESC.CCN(CC)C(=O)c1cccc(Nc2nc3ccc(-c4cncc(OC)c4)cc3s2)n1.CCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.CCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.CNC(=O)Cn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.COCCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.Cc1cncc(-c2ccc3nc(Nc4ccc(C)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccc(N5CCOCC5)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccnn4C)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4cnn(C)c4)sc3c2)c1
InChIInChI=1S/C23H23N5O2S.C22H21N5OS.C19H18N6OS.C19H19N5OS.C19H16N4S.2C18H17N5S.2C17H15N5S.CH4/c1-4-28(5-2)22(29)19-7-6-8-21(25-19)27-23-26-18-10-9-15(12-20(18)31-23)16-11-17(30-3)14-24-13-16;1-15-10-17(13-23-12-15)16-2-4-19-20(11-16)29-22(26-19)25-18-3-5-21(24-14-18)27-6-8-28-9-7-27;1-12-5-14(8-21-7-12)13-3-4-16-17(6-13)27-19(24-16)23-15-9-22-25(10-15)11-18(26)20-2;1-13-7-15(10-20-9-13)14-3-4-17-18(8-14)26-19(23-17)22-16-11-21-24(12-16)5-6-25-2;1-12-7-15(10-20-9-12)14-4-6-17-18(8-14)24-19(23-17)22-16-5-3-13(2)21-11-16;2*1-3-23-11-15(10-20-23)21-18-22-16-5-4-13(7-17(16)24-18)14-6-12(2)8-19-9-14;1-11-5-13(8-18-7-11)12-3-4-15-16(6-12)23-17(21-15)20-14-9-19-22(2)10-14;1-11-7-13(10-18-9-11)12-3-4-14-15(8-12)23-17(20-14)21-16-5-6-19-22(16)2;/h6-14H,4-5H2,1-3H3,(H,25,26,27);2-5,10-14H,6-9H2,1H3,(H,25,26);3-10H,11H2,1-2H3,(H,20,26)(H,23,24);3-4,7-12H,5-6H2,1-2H3,(H,22,23);3-11H,1-2H3,(H,22,23);2*4-11H,3H2,1-2H3,(H,21,22);2*3-10H,1-2H3,(H,20,21);1H4
InChIKeyBFFIXQCCFYHODU-UHFFFAOYSA-N
MW3243.14 g/mol
LogP40.53
Rot. Bonds39

About N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine

N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine (PubChem CID 157330416) has the molecular formula C173H165N45O5S9 and a molecular weight of 3243.14 g/mol. Its IUPAC name is N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine.

Molecular Properties

Compound NameN,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine
PubChem CID157330416
Molecular FormulaC173H165N45O5S9
Molecular Weight3243.14 g/mol
Exact Mass3240.15
IUPAC NameN,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine
SMILESC.CCN(CC)C(=O)c1cccc(Nc2nc3ccc(-c4cncc(OC)c4)cc3s2)n1.CCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.CCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.CNC(=O)Cn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.COCCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.Cc1cncc(-c2ccc3nc(Nc4ccc(C)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccc(N5CCOCC5)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccnn4C)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4cnn(C)c4)sc3c2)c1
InChIInChI=1S/C23H23N5O2S.C22H21N5OS.C19H18N6OS.C19H19N5OS.C19H16N4S.2C18H17N5S.2C17H15N5S.CH4/c1-4-28(5-2)22(29)19-7-6-8-21(25-19)27-23-26-18-10-9-15(12-20(18)31-23)16-11-17(30-3)14-24-13-16;1-15-10-17(13-23-12-15)16-2-4-19-20(11-16)29-22(26-19)25-18-3-5-21(24-14-18)27-6-8-28-9-7-27;1-12-5-14(8-21-7-12)13-3-4-16-17(6-13)27-19(24-16)23-15-9-22-25(10-15)11-18(26)20-2;1-13-7-15(10-20-9-13)14-3-4-17-18(8-14)26-19(23-17)22-16-11-21-24(12-16)5-6-25-2;1-12-7-15(10-20-9-12)14-4-6-17-18(8-14)24-19(23-17)22-16-5-3-13(2)21-11-16;2*1-3-23-11-15(10-20-23)21-18-22-16-5-4-13(7-17(16)24-18)14-6-12(2)8-19-9-14;1-11-5-13(8-18-7-11)12-3-4-15-16(6-12)23-17(21-15)20-14-9-19-22(2)10-14;1-11-7-13(10-18-9-11)12-3-4-14-15(8-12)23-17(20-14)21-16-5-6-19-22(16)2;/h6-14H,4-5H2,1-3H3,(H,25,26,27);2-5,10-14H,6-9H2,1H3,(H,25,26);3-10H,11H2,1-2H3,(H,20,26)(H,23,24);3-4,7-12H,5-6H2,1-2H3,(H,22,23);3-11H,1-2H3,(H,22,23);2*4-11H,3H2,1-2H3,(H,21,22);2*3-10H,1-2H3,(H,20,21);1H4
InChIKeyBFFIXQCCFYHODU-UHFFFAOYSA-N
XLogP40.53
TPSA566.22 Ų
H-Bond Donors10
H-Bond Acceptors57
Rotatable Bonds39
Heavy Atoms232
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003243.14
LogP ≤ 540.53
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1057

Analyze N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine?
The IUPAC name of N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine (CID 157330416) is N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine.
What is the SMILES notation for N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine?
The canonical SMILES for N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine is C.CCN(CC)C(=O)c1cccc(Nc2nc3ccc(-c4cncc(OC)c4)cc3s2)n1.CCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.CCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.CNC(=O)Cn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.COCCn1cc(Nc2nc3ccc(-c4cncc(C)c4)cc3s2)cn1.Cc1cncc(-c2ccc3nc(Nc4ccc(C)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccc(N5CCOCC5)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccnn4C)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4cnn(C)c4)sc3c2)c1.
What is the InChIKey of N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine?
The InChIKey is BFFIXQCCFYHODU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23N5O2S.C22H21N5OS.C19H18N6OS.C19H19N5OS.C19H16N4S.2C18H17N5S.2C17H15N5S.CH4/c1-4-28(5-2)22(29)19-7-6-8-21(25-19)27-23-26-18-10-9-15(12-20(18)31-23)16-11-17(30-3)14-24-13-16;1-15-10-17(13-23-12-15)16-2-4-19-20(11-16)29-22(26-19)25-18-3-5-21(24-14-18)27-6-8-28-9-7-27;1-12-5-14(8-21-7-12)13-3-4-16-17(6-13)27-19(24-16)23-15-9-22-25(10-15)11-18(26)20-2;1-13-7-15(10-20-9-13)14-3-4-17-18(8-14)26-19(23-17)22-16-11-21-24(12-16)5-6-25-2;1-12-7-15(10-20-9-12)14-4-6-17-18(8-14)24-19(23-17)22-16-5-3-13(2)21-11-16;2*1-3-23-11-15(10-20-23)21-18-22-16-5-4-13(7-17(16)24-18)14-6-12(2)8-19-9-14;1-11-5-13(8-18-7-11)12-3-4-15-16(6-12)23-17(21-15)20-14-9-19-22(2)10-14;1-11-7-13(10-18-9-11)12-3-4-14-15(8-12)23-17(20-14)21-16-5-6-19-22(16)2;/h6-14H,4-5H2,1-3H3,(H,25,26,27);2-5,10-14H,6-9H2,1H3,(H,25,26);3-10H,11H2,1-2H3,(H,20,26)(H,23,24);3-4,7-12H,5-6H2,1-2H3,(H,22,23);3-11H,1-2H3,(H,22,23);2*4-11H,3H2,1-2H3,(H,21,22);2*3-10H,1-2H3,(H,20,21);1H4.
What are the key properties of N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine?
N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine has a molecular weight of 3243.14 g/mol, XLogP of 40.53, 39 rotatable bonds, 10 hydrogen bond donors, and 57 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-diethyl-6-[[6-(5-methoxy-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyridine-2-carboxamide;bis(N-(1-ethylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine);methane;N-[1-(2-methoxyethyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-methyl-2-[4-[[6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-yl]amino]pyrazol-1-yl]acetamide;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;N-(2-methylpyrazol-3-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine is sourced from PubChem (CID 157330416), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).